Urolog. pro Praxi, 2008; 9(4): 160-164

Locally advanced prostate cancer

MUDr. Miloš Broďák Ph.D2, MUDr. Jaroslav Pacovský1, MUDr. Josef Košina2, et al
1 Urologické klinika FN a LF UK Hradec Králové, Regionální transplantační centrum Hradec Králové
2 Urologická klinika FN a LF UK Hradec Králové

The management of locally advanced prostate cancer remains very controversy issue. The incidence of this stage drops due to wide using PSA test and early detection methods. The most common treatment method is radiotherapy with neoadjuvant hormonal blockade, recently radical prostatectomy is performed more and more frequently, especially in low-risk patients. Androgen deprivation therapy is another method of treatment for high risk patients with contraindication for local treatment, with early or deferred initiation.

Keywords: locally advanced prostate cancer, radiotherapy, radical prostatectomy

Published: December 19, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Broďák M, Pacovský J, Košina J, al E. Locally advanced prostate cancer. Urol. praxi. 2008;9(4):160-164.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol. 2003; 169: 849-854. Go to original source... Go to PubMed...
    2. Brassell SA, Rosner IL, McLeod DG. Update on magnetic resonance imaging, ProstaScint and novel imaging in prostate cancer. Curr Opin Urol. 2005; 15: 163-166. Go to original source... Go to PubMed...
    3. Cadeddu JA, Partin AW, Epstein JI, and Walsh PC. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 1997; 50: 251-255. Go to original source... Go to PubMed...
    4. Hakenberg OW, Froehner M, Wirth MP. Treatment of locally advanced prostate cancer - the case for radical prostatectomy. Urol Int. 2006; 77: 193-199. Go to original source... Go to PubMed...
    5. Hsu CY, Joniau S, Oyen R, Roskams T, Van Poppel H. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol. 2007; 51: 121-129. Go to original source... Go to PubMed...
    6. Isorna Martinez de la Riva S, Belon Lopez-Tomasety J, Marrero Dominguez R, Alvarez Cruz E, Santamaria Blanco P. Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up. Arch Esp Urol. 2004; 57(7): 679-692. Go to PubMed...
    7. Matoušková M, Hanuš M. Cena hormonální léčby karcinomu prostaty - farmakoekonomické aspekty léčby. Urolog. pro Praxi, 2008; 9(1): 24-27.
    8. Partin AW, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001; 58(6): 843-848. Go to original source... Go to PubMed...
    9. Pavlík I. Lokálně pokročilý karcinom prostaty - blýská se na lepší časy nebo jen dál pokračuje hra s hormony? Urolog. pro Praxi, 2006; 184-186.
    10. Pilepich, MV, Winter MS, John MJ, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2001; 50(5): 1243-1252. Go to original source... Go to PubMed...
    11. Van Poppel H, Goethuys H, Callewaert P, Vanuytsel L, van de Voorde W, Baert L. Radical prostatectomy can provide cure for well selected clinical stage T3 prostate cancer. Eur Urol. 2000; 38: 372-379. Go to original source... Go to PubMed...
    12. Roach M 3rd et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1994; 28(1): 33-37. Go to original source... Go to PubMed...
    13. Ward JF, Slezak JM, Blute ML, Bergstrahl EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005; 95: 751-756. Go to original source... Go to PubMed...
    14. Zelefsky MJ, Yamada Y, Kollmeier MA, et al. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer. Eur Urol. 2008; 31: 53(6): 1172-1179. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.